Gemcitabine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Gemcitabine. Educational only — not medical advice.
Labeled uses
INLEXZO is indicated for the treatment of adult patients with Bacillus Calmette-Guérin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.
Source: FDA labeling via NIH DailyMed (set 3aef8dbc…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.